Former United Nations Secretary-General Kofi Annan underlined the need for global action: "Across the world, the threat [of diabetes] is ignored and under-funded. Tackling diabetes must be a priority. It is so serious that we all have to be involved if we are to reverse this epidemic."
The annual direct costs of diabetes in China in 2004 were estimated at RMB 57,469 billion, about 7.5 % of total healthcare spending. Direct spending for a person with diabetes was 2.5 times more than for a person without it. Furthermore, two-thirds of Chinese people who have diabetes do not realise they have it until they start to develop its late-stage and costly complications such as damage to eyes, kidneys and heart. Diagnosing diabetes earlier and giving proper care will reduce healthcare costs by preventing or delaying the development of such complications.
"We need to learn how to handle the increasing number of people with chronic diseases and build healthcare systems that can effectively deal with the new situation," said Anil Kapur, managing director of the World Diabetes Foundation, stressing the need to find a model that balances community-based prevention and care with hospital-based acute care.
Lars Rebien Sørensen, president and CEO of Novo Nordisk, said: "Novo Nordisk is proud to support the dialogue in China around solutions to tackle the diabetes epidemic. The key to change the course of diabetes lies in prevention, early detection, access to care, and improved treatment. That way, we not only reduce the number of people who develop diabetes in the first place, but we also increase our capacity to tackle complications more effectively, and ultimately reduce the cost to society."
The Chinese Diabetes Society and the Chinese Centre for Disease Control have organised the Diabetes Leadership Forum 2009 China with the support of the International Diabetes Federation. Novo Nordisk, a healthcare company and a world leader in diabetes care, has sponsored the event.
Contributed by: Bobby Ramakant
Source-Medindia
SRM